Not an eMediNexus Member?
In patients with refractory renal cell carcinoma (RCC), third- or fourth-line tivozanib improved progression-free survival and w ...MORE
Results from the randomized, phase III KEYNOTE-426 clinical trial show that first-line therapy with a combination of the PD-1 ta ...MORE
Older adults who initiate dialysis for kidney failure are at a greater risk of being diagnosed with dementia and Alzheimer’s disease. Age ≥86 years, ...MORE
Sunitinib alone was not inferior to nephrectomy followed by sunitinib in patients with metastatic clear-cell renal-cell carcinoma who were classified as havi ...MORE
Treatment with sunitinib alone was not inferior to cytoreductive nephrectomy followed by sunitinib in patients with metastatic renal cell carcinoma who were ...MORE
Patients with previously untreated metastatic renal cell cancer (mRCC), combining immunotherapy atezolizumab with targeted therapy bevacizumab delayed cancer ...MORE